Company Active LTD

Company profile

Linkgevity Limited

Linkgevity - AI-enabled drug discovery company

Discover the future of medicine with Linkgevity, a cutting-edge AI-enabled drug discovery company. Our revolutionary approach combines the power of artificial intelligence and pharmaceutical expertise to accelerate the development of life-changing medications. Join us in shaping the healthcare landscape and unlocking new possibilities for improved treatments and cures

CRN
14732203
Founded
2023
Age
3

Overview

Legal name
LINKGEVITY LIMITED
Region
London
Registered address
3RD FLOOR
114A CROMWELL ROAD
LONDON
UNITED KINGDOM
SW7 4AG
Insolvency history
No

Latest accounts

Financial period: 1 Apr 2024 to 31 Mar 2025

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
1

Company events

Reference milestones and recent Companies House filing stream events.

20 events
28 Mar
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

26 Mar
2026

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzUxMjgwMTQwOWFkaXF6a2N4

Published 26 Mar 2026 16:02

26 Mar
2026

Capital Allotment Shares

Capital

SH01 | Transaction MzUxMjU2NjQ3N2FkaXF6a2N4

Published 26 Mar 2026 15:40

26 Mar
2026

Capital Allotment Shares

Capital

SH01 | Transaction MzUxMjU2NjQ4MGFkaXF6a2N4

Published 26 Mar 2026 15:40

25 Mar
2026

Capital Allotment Shares

Capital

SH01 | Transaction MzUxMjU2NjQ3M2FkaXF6a2N4

Published 25 Mar 2026 16:40

14 Mar
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

26 Nov
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQ0NDkwMTI4MWFkaXF6a2N4

Published 26 Nov 2024 10:06

14 Nov
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQ0MzA2MzMzN2FkaXF6a2N4

Published 14 Nov 2024 12:59

13 Nov
2024

Second Filing Capital Allotment Shares

Capital

RP04SH01 | Transaction MzQ0MjQ1NTQ2NWFkaXF6a2N4

Published 13 Nov 2024 12:45

13 Nov
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQ0MzA2MzMzNGFkaXF6a2N4

Published 13 Nov 2024 01:56

13 Nov
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQ0MzA2MzMzNmFkaXF6a2N4

Published 13 Nov 2024 01:56

13 Nov
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQ0MzA2MzMzMmFkaXF6a2N4

Published 13 Nov 2024 01:56

13 Nov
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQ0MzA2MzMzM2FkaXF6a2N4

Published 13 Nov 2024 01:56

16 Oct
2024

Cessation Of A Person With Significant Control

Persons-with-significant-control

PSC07 | Transaction MzQzOTUzMjQ3MmFkaXF6a2N4

Published 16 Oct 2024 10:16

15 Oct
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQzOTU2MTA4NGFkaXF6a2N4 | Paper/PDF filed

Published 19 Nov 2024 02:21

15 Oct
2024

Change To A Person With Significant Control

Persons-with-significant-control

PSC04 | Transaction MzQzOTUzMjQxMGFkaXF6a2N4

Published 15 Oct 2024 09:27

20 Aug
2024

Resolution

Resolution

RESOLUTIONS | Transaction WUQ5SDMxTThhZGlxemtjeA | Paper/PDF filed

Published 21 Aug 2024 07:50

15 Mar
2023

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2024
Funded years
2024
Age at first award
1 years

Projects

2024 Collaborative R&D Lead participant

Revolutionising Organ Preservation: Innovative Anti-Necrotic Technology for Enhanced Viability and Equity in Transplantation

1 Dec 2024 to 31 Jan 2026

Awarded
£234,541
Total cost £335,058

UK-based biotech SME LinkGevity is led by a diverse and experienced project team. At the helm is Dr Carina Kern, a pioneering female scientist, who is responsible for developing LinkGevity's unique Anti-Necrotic. Despite the concerning and growing scarcity of transplant organs, 80% of transplantable organs are ultimately wasted due to damage caused by nec...

Product types

Collaborative R&D